148 related articles for article (PubMed ID: 12578494)
1. Prevention of contrast nephropathy.
Curhan GC
JAMA; 2003 Feb; 289(5):606-8. PubMed ID: 12578494
[No Abstract] [Full Text] [Related]
2. Acetylcysteine and renal function following coronary angiographic procedures.
Bagshaw SM; Culleton BF
JAMA; 2003 Jun; 289(21):2795; author reply 2796. PubMed ID: 12783908
[No Abstract] [Full Text] [Related]
3. Acetylcysteine and renal function following coronary angiographic procedures.
Balderramo DC
JAMA; 2003 Jun; 289(21):2795-6; author reply 2796. PubMed ID: 12783907
[No Abstract] [Full Text] [Related]
4. Does N-acetylcysteine prevent contrast-induced nephropathy?
Vaitkus PT
Am J Cardiol; 2002 Dec; 90(12):1424; author reply 1424-5. PubMed ID: 12480065
[No Abstract] [Full Text] [Related]
5. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
7. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).
Diaz-Sandoval LJ; Kosowsky BD; Losordo DW
Am J Cardiol; 2002 Feb; 89(3):356-8. PubMed ID: 11809444
[No Abstract] [Full Text] [Related]
8. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
Bouzas-Mosquera A; Vázquez-Rodríguez JM
Am J Cardiol; 2008 Mar; 101(6):910. PubMed ID: 18328863
[No Abstract] [Full Text] [Related]
9. Acetylcysteine and renal function following coronary angiographic procedures.
Shen AY
JAMA; 2003 Jun; 289(21):2794-5; author reply 2796. PubMed ID: 12783905
[No Abstract] [Full Text] [Related]
10. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
Safirstein R; Andrade L; Vieira JM
N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
[No Abstract] [Full Text] [Related]
11. Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?
Ma IW; Hladunewich M
CMAJ; 2004 Apr; 170(8):1231. PubMed ID: 15078844
[No Abstract] [Full Text] [Related]
12. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
[TBL] [Abstract][Full Text] [Related]
13. Protection from contrast-induced nephropathy: is the answer in?
Dean LS
Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
[No Abstract] [Full Text] [Related]
14. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.
Anderson SM; Park ZH; Patel RV
Ann Pharmacother; 2011 Jan; 45(1):101-7. PubMed ID: 21205947
[TBL] [Abstract][Full Text] [Related]
15. Contrast nephropathy after coronary angiography.
Gami AS; Garovic VD
Mayo Clin Proc; 2004 Feb; 79(2):211-9. PubMed ID: 14959916
[TBL] [Abstract][Full Text] [Related]
16. [Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Deray G
J Radiol; 2004 Jun; 85(6 Pt 1):725-7. PubMed ID: 15243372
[TBL] [Abstract][Full Text] [Related]
17. Acetylcysteine and contrast media nephropathy.
Tepel M; Zidek W
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):503-6. PubMed ID: 12187314
[TBL] [Abstract][Full Text] [Related]
18. How to protect from contrast media-induced nephropathy?
Scheller B
Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
[No Abstract] [Full Text] [Related]
19. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine for radiocontrast nephropathy.
Tepel M; Zidek W
Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
